gastroparesis and semaglutide Ozempic & Stomach Problems Risk of gastroparesis with common

For context, semaglutide and tirzepatide do not produce dysesthesia at clinically significant rates, though a recent paper in PMC examined allodynia and dysesthesia reports across GLP-1 medications more broadly

As these medications reduce overall energy intake, individuals are consuming fewer calories with estimates placing this reduction between 16 and 39%, or about 700 calories per day on average (Christensen et al., 2024)

Let's be honest, this is crucial for study design and interpretation

Su M-H, Shih Y-H, Lin Y-F, Chen P-C, Chen C-Y, Hsiao P-C, et al

Eli Lilly and Company 's LLY stock has risen 18% in a month, driven mainly by a stellar third-quarter performance

Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial